Unique ID issued by UMIN | UMIN000041204 |
---|---|
Receipt number | R000047051 |
Scientific Title | Observation of atopic dermatitis in high-performance shower heads with a general shower head as a control Double-blind randomized trial |
Date of disclosure of the study information | 2020/07/24 |
Last modified on | 2021/01/13 16:57:42 |
Observation of atopic dermatitis in high-performance shower heads with a general shower head as a control Double-blind randomized trial
Observation of atopic dermatitis in high-performance shower heads with a general shower head as a control Double-blind randomized trial
Observation of atopic dermatitis in high-performance shower heads with a general shower head as a control Double-blind randomized trial
Observation of atopic dermatitis in high-performance shower heads with a general shower head as a control Double-blind randomized trial
Japan |
Atopic dermatitis
Dermatology |
Others
NO
To compare the improvement of atopic dermatitis after using a high performance shower head for 12 weeks with general shower head
Safety,Efficacy
Evaluation prescribed in "Atopic Dermatitis Practice Guideline 2018" established by the Japanese Dermatological Association
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
2
Treatment
Other |
High performance shower head
General shower head
18 | years-old | <= |
Not applicable |
Male and Female
1) Men and women over the age of 18 diagnosed with atopic dermatitis
2) Those who can only use the shower during the test period
3) Those who have agreed to take a picture of the affected area
4) Those who can install the shower head specified in the test
5) Can obtain written consent
1) There are skin diseases other than atopic dermatitis such as burns
2) With tattoos and tattoos
3) May become pregnant during pregnancy or during the study period
4) Heart disease, cerebrovascular disease, arrhythmia, history of dizziness and being affected
5) Systolic blood pressure at screening is 170 mmHg or more or diastolic blood pressure is 110 mmHg or more. However, those taking antihypertensive drugs have systolic blood pressure of 150 mmHg or more.
6) May be in need of treatment during treatment or for malignant tumor
7) Surgical operation was performed within 6 months from the time of screening, or radiotherapy for malignant tumor.
8) The investigator determined that he was unsuitable as a researcher
60
1st name | Masahiro |
Middle name | |
Last name | Takashima |
Takashima Clinic
Critical Research
5560011
1-13-2, Namba-naka, naniwa-ku, Osaka
06-6606-9090
f-sato@qolife.jp
1st name | Fumihiko |
Middle name | |
Last name | Sato |
Takashima Clinic
Critical Research
5560011
1-13-2, Namba-naka, naniwa-ku, Osaka
06-6606-9090
f-sato@qolife.jp
Takashima Clinic
Science, Co, ltd
Profit organization
Takashima Clinic Ethics Committee
1-13-2, Namba-naka, naniwa-ku, Osaka
06-6606-9090
f-sato@qolife.jp
NO
2020 | Year | 07 | Month | 24 | Day |
Unpublished
57
Completed
2020 | Year | 05 | Month | 13 | Day |
2020 | Year | 05 | Month | 13 | Day |
2020 | Year | 06 | Month | 15 | Day |
2020 | Year | 09 | Month | 30 | Day |
2020 | Year | 10 | Month | 31 | Day |
2021 | Year | 01 | Month | 12 | Day |
2021 | Year | 01 | Month | 31 | Day |
2020 | Year | 07 | Month | 24 | Day |
2021 | Year | 01 | Month | 13 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047051